Cargando…
Pharmacological Inhibition of Myostatin in a Mouse Model of Typical Nemaline Myopathy Increases Muscle Size and Force
Nemaline myopathy is one of the most common non-dystrophic congenital myopathies. Individuals affected by this condition experience muscle weakness and muscle smallness, often requiring supportive measures like wheelchairs or respiratory support. A significant proportion of patients, approximately o...
Autores principales: | Lindqvist, Johan, Granzier, Henk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606666/ https://www.ncbi.nlm.nih.gov/pubmed/37894805 http://dx.doi.org/10.3390/ijms242015124 |
Ejemplares similares
-
Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy
por: Lindqvist, Johan, et al.
Publicado: (2019) -
Removal of MuRF1 Increases Muscle Mass in Nemaline Myopathy Models, but Does Not Provide Functional Benefits
por: Lindqvist, Johan, et al.
Publicado: (2022) -
Triggering typical nemaline myopathy with compound heterozygous nebulin mutations reveals myofilament structural changes as pathomechanism
por: Lindqvist, Johan, et al.
Publicado: (2020) -
Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations
por: de Winter, Josine Marieke, et al.
Publicado: (2013) -
Modulating myosin restores muscle function in a mouse model of nemaline myopathy
por: Lindqvist, Johan, et al.
Publicado: (2016)